Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LHW090 in patients with moderately impaired renal function on ARBs
NCT02678000Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of LHW090 in chronic kidney disease (CKD), sponsored by Novartis. Started Mar 2017; status: completed.
02
Drugs
LHW090
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02678000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678000.